Department of Neurology, Brain and Spinal Injury Center, University of California, San Francisco, and Room 4M62, San Francisco General Hospital, 1001 Potrero Avenue, San Francisco, CA 94110, USA.
Stroke. 2011 Oct;42(10):2944-6. doi: 10.1161/STROKEAHA.111.617639. Epub 2011 Jul 28.
Previous studies of intracerebral hemorrhage (ICH) outcome prediction models have not systematically included adjustment for comorbid conditions. The purpose of this study was to assess whether the Charlson Comorbidity Index (CCI) was associated with early mortality and long-term functional outcome in patients with intracerebral hemorrhage.
We performed a retrospective analysis on a prospective observational cohort of patients with ICH admitted to 2 University of California San Francisco hospitals from June 1, 2001 to May 31, 2004. Components of the ICH score and use of early care limitations were recorded. Outcome was assessed using the modified Rankin Scale to 12 months. The CCI was derived using hospital discharge International Classification of Diseases, revision 9 codes and patient history obtained from standardized case report forms.
In this cohort of 243 ICH patients, comorbid conditions were common, with CCI scores ranging from 0 to 12. Only 29% of patients with high CCI scores (≥3) achieved a 12-month modified Rankin Scale score of ≥3 compared with 48% of patients with CCI scores of 0 (P=0.02). CCI score was independently predictive of 12-month functional outcome, with higher CCI having a greater impact (CCI=2: odds ratio, 2.3; P=0.06; CCI=≥3: odds ratio, 3.5; P=0.001).
Comorbid medical conditions as measured by the CCI independently influence outcome after ICH. Future ICH outcome studies should account for the impact of comorbidities on patient outcome.
既往关于脑出血(ICH)预后预测模型的研究并未系统地纳入合并症调整。本研究旨在评估Charlson 合并症指数(CCI)与ICH 患者的早期死亡率和长期功能结局是否相关。
我们对 2001 年 6 月 1 日至 2004 年 5 月 31 日期间在加利福尼亚大学旧金山分校 2 家医院住院的ICH 前瞻性观察队列进行了回顾性分析。记录 ICH 评分的组成部分和早期护理限制的使用情况。使用改良 Rankin 量表在 12 个月时评估结局。CCI 通过医院出院国际疾病分类,修订版 9 代码和标准化病例报告表中获得的患者病史来确定。
在这 243 例 ICH 患者队列中,合并症很常见,CCI 评分范围为 0 至 12。高 CCI 评分(≥3)患者中只有 29%在 12 个月时达到改良 Rankin 量表评分≥3,而 CCI 评分为 0 的患者中则有 48%(P=0.02)。CCI 评分独立预测 12 个月的功能结局,CCI 评分越高影响越大(CCI=2:比值比,2.3;P=0.06;CCI≥3:比值比,3.5;P=0.001)。
CCI 衡量的合并医疗条件独立影响 ICH 后的结局。未来的 ICH 结局研究应考虑合并症对患者结局的影响。